In the past few years, med-tech start-ups have had to face some steep challenges in securing venture capital funding. VC's are more skittish about investing in med-tech companies for a variety of different reasons, which include the state of today's economy and an unpredictable regulatory approval process. The very nature of funding rounds is changing.